January 11, 2026
11 11 11 AM
We Can, We Will, We Must Update You on Where the Cheer Cast Is Now
Iran protesters defy crackdown as videos show violent clashes
20 Shocking Secrets About The Sopranos Revealed
Trump says US needs to ‘own’ Greenland to prevent Russia and China from taking it
The Best Dressed Celebrities in Golden Globes Red Carpet History
The Heartbreaking Truth About Elvis and Priscilla Presley’s Love Story
1000-lb Sisters’ Amy Slaton & Brian Lovvorn’s Scary-Perfect Love Story
Who Needs a Vowel? We’d Like to Buy These Wheel of Fortune Secrets
Venezuela swears in interim president after defiant Maduro pleads not guilty
Timothée Chalamet Confirms Kylie Jenner Relationship Timeline
Latest Post
We Can, We Will, We Must Update You on Where the Cheer Cast Is Now Iran protesters defy crackdown as videos show violent clashes 20 Shocking Secrets About The Sopranos Revealed Trump says US needs to ‘own’ Greenland to prevent Russia and China from taking it The Best Dressed Celebrities in Golden Globes Red Carpet History The Heartbreaking Truth About Elvis and Priscilla Presley’s Love Story 1000-lb Sisters’ Amy Slaton & Brian Lovvorn’s Scary-Perfect Love Story Who Needs a Vowel? We’d Like to Buy These Wheel of Fortune Secrets Venezuela swears in interim president after defiant Maduro pleads not guilty Timothée Chalamet Confirms Kylie Jenner Relationship Timeline

Intranasal vaccine against H5 avian flu provokes broad immune response in adults in phase 1 trial

Three of five groups of eight participants each received low, medium, or high doses of the clade 2.1 influenza A/H5 (A/Indonesia/05/2005) recombinant hemagglutinin glycoprotein (rH5) vaccine combined with an adjuvant; one group received 100 µg of an unadjuvanted rH5 vaccine; and one group received placebo. All participants received an intramuscular H5 booster 6 months later.

Participants who received the adjuvanted vaccine had higher levels of protective antibodies (immunoglobulin [Ig] G and A), more memory immune cells, and a better ability to neutralize infected cells.

Only recipients of the boosted intranasal vaccine showed strong immune priming. Even without a booster, the intranasal vaccine triggered mucosal and systemic immunity, which other intranasal recombinant H5 flu vaccines have not achieved in clinical trials. It also was safe and well-tolerated.

The immune system’s ability to recognize multiple strains of H5N1 virus is key because they change over time, co-lead author Meagan Deming, MD, PhD, said in a university news release. “The use of the adjuvant also suggests this approach might allow for lower doses of the vaccine, which could make our current vaccine stocks available to more people in the event of an outbreak,” she said.

Corresponding author Justin Ortiz, MD, said that global transmission of H5N1 in animals, including spillover into people, underscores the need for effective countermeasures. “This trial shows that this intranasal, shelf-stable H5N1 vaccine could play a major role in pandemic preparedness, offering a practical and scalable way to help protect people from evolving strains of the virus,” he said.

10 thoughts on “Intranasal vaccine against H5 avian flu provokes broad immune response in adults in phase 1 trial

  1. Your blog is a testament to your dedication to your craft. Your commitment to excellence is evident in every aspect of your writing. Thank you for being such a positive influence in the online community.

  2. I just wanted to drop by and say how much I appreciate your blog. Your writing style is both engaging and informative, making it a pleasure to read. Looking forward to your future posts!

  3. Hello Neat post Theres an issue together with your site in internet explorer would check this IE still is the marketplace chief and a large element of other folks will leave out your magnificent writing due to this problem

  4. Your blog is a testament to your dedication to your craft. Your commitment to excellence is evident in every aspect of your writing. Thank you for being such a positive influence in the online community.

Leave a Reply

Your email address will not be published. Required fields are marked *